As part of the preparations for the SPARKLE image re-evaluation, the new independent readers have successfully completed the training program according to plan. The image reading process has now started and the first patient images have been evaluated. The re-evaluation is on track to report headline results by
“The most important factors for obtaining consistent results are the selection and training of readers, and the scheduling and monitoring of the image reading flow. In the re-evaluation, we have diligently developed these elements to ensure that reliable results will be obtained by May 2024”, says
“We are dedicated to making Orviglance available for cancer patients with kidney impairment. Today’s announcement marks an important milestone towards being able to report efficacy results from SPARKLE. The planning and preparation phase of the re-evaluation is now completed, and the start of the image reading puts us on track for reporting results by May next year”, says Magnus Corfitzen, CEO of
© Modular Finance, source